UICC report flags air pollution as major multi-cancer risk

The long-term exposure to fine particulate matter (PM2.5) increases overall cancer risk by 11%

C-CAMP hosts first National Diagnostics Conclave, unveils key reports and tools

Marking three years of the National Diagnostics Catapult (NDxC), the conclave launched the Impact Report and unveiled environmental surveillance kits

Aurobindo Pharma wins key FDA nod for $138M US cough drug market entry

The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation

Aurobindo Pharma wins USFDA nod for rare disease drug set for immediate launch

GE HealthCare expands DeepHealth AI partnership to supercharge breast cancer detection

The move aims to accelerate the development, commercialization, and global rollout of advanced AI-powered mammography tools

FDA pushes forward on gene-editing therapies with new safety roadmap

Genome editing holds extraordinary promise for treating previously incurable genetic diseases

Precision BioSciences expands Hepatitis B gene editing trial into France and Romania

The Clinical Trial Application (CTA) approval clears the way for the company to launch trial locations in France and Romania

Stereotaxis to acquire Robocath in deal aimed at expanding surgical robotics platform

Philips wins FDA nod for AI-powered spectral CT system Verida

At the core of Verida is Spectral Precise Image technology paired with a third-generation Nano-panel Precise dual-layer detector and an AI-based deep learning reconstruction engine

Takara Bio and Resistomap forge deal to speed up global fight against superbugs

The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence